Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Szadai L, Bartha A, Parada IP, Lakatos A, Pál D, Lengyel AS, de Almeida NP, Jánosi ÁJ, Nogueira F, Szeitz B, Doma V, Woldmar N, Guedes J, Ujfaludi Z, Pahi ZG, Pankotai T, Kim Y, Győrffy B, Baldetorp B, Welinder C, Szasz AM, Betancourt L, Gil J, Appelqvist R, Kwon HJ, Kárpáti S, Kuras M, Murillo JR, Németh IB, Malm J, Fenyö D, Pawłowski K, Horvatovich P, Wieslander E, Kemény LV, Domont G, MarkoVarga G, Sanchez A. Szadai L, et al. Among authors: nemeth ib. bioRxiv [Preprint]. 2024 May 4:2024.05.01.592032. doi: 10.1101/2024.05.01.592032. bioRxiv. 2024. Update in: Front Oncol. 2024 Jul 02;14:1428182. doi: 10.3389/fonc.2024.1428182 PMID: 38746333 Free PMC article. Updated. Preprint.
Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction.
Pla I, Szabolcs BL, Péter PN, Ujfaludi Z, Kim Y, Horvatovich P, Sanchez A, Pawlowski K, Wieslander E, Guedes J, Pál DM, Ascsillán AA, Betancourt LH, Németh IB, Gil J, de Almeida NP, Szeitz B, Szadai L, Doma V, Woldmar N, Bartha Á, Pahi Z, Pankotai T, Győrffy B, Szasz AM, Domont G, Nogueira F, Kwon HJ, Appelqvist R, Kárpáti S, Fenyö D, Malm J, Marko-Varga G, Kemény LV. Pla I, et al. Among authors: nemeth ib. bioRxiv [Preprint]. 2024 Feb 12:2024.02.08.579424. doi: 10.1101/2024.02.08.579424. bioRxiv. 2024. PMID: 38545623 Free PMC article. Preprint.
MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species.
Roider E, Lakatos AIT, McConnell AM, Wang P, Mueller A, Kawakami A, Tsoi J, Szabolcs BL, Ascsillán AA, Suita Y, Igras V, Lo JA, Hsiao JJ, Lapides R, Pál DMP, Lengyel AS, Navarini A, Okazaki A, Iliopoulos O, Németh I, Graeber TG, Zon L, Giese RW, Kemeny LV, Fisher DE. Roider E, et al. bioRxiv [Preprint]. 2023 Nov 14:2023.11.10.564582. doi: 10.1101/2023.11.10.564582. bioRxiv. 2023. Update in: Sci Rep. 2024 Sep 14;14(1):21527. doi: 10.1038/s41598-024-72031-9 PMID: 38014031 Free PMC article. Updated. Preprint.
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes.
Pla I, Szabolcs BL, Péter PN, Ujfaludi Z, Kim Y, Horvatovich P, Sanchez A, Pawlowski K, Wieslander E, Kuras M, Murillo JR, Guedes J, Pál DMP, Ascsillán AA, Betancourt LH, Németh IB, Gil J, de Almeida NP, Szeitz B, Szadai L, Doma V, Woldmar N, Bartha Á, Pahi Z, Pankotai T, Győrffy B, Szasz AM, Domont G, Nogueira F, Kwon HJ, Appelqvist R, Kárpáti S, Fenyö D, Malm J, Marko-Varga G, Kemény LV. Pla I, et al. Among authors: nemeth ib. Int J Dermatol. 2024 Dec 25. doi: 10.1111/ijd.17586. Online ahead of print. Int J Dermatol. 2024. PMID: 39722169
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.
Pinto de Almeida N, Jánosi ÁJ, Hong R, Rajeh A, Nogueira F, Szadai L, Szeitz B, Pla Parada I, Doma V, Woldmar N, Guedes J, Újfaludi Z, Bartha A, Kim Y, Welinder C, Baldetorp B, Kemény LV, Pahi Z, Wan G, Nguyen N, Pankotai T, Győrffy B, Pawłowski K, Horvatovich P, Szasz AM, Sanchez A, Kuras M, Rodriguez Murillo J, Betancourt L, Domont GB, Semenov YR, Yu KH, Kwon HJ, Németh IB, Fenyő D, Wieslander E, Marko-Varga G, Gil J. Pinto de Almeida N, et al. Among authors: nemeth ib. Clin Transl Med. 2024 Jul;14(7):e1773. doi: 10.1002/ctm2.1773. Clin Transl Med. 2024. PMID: 39032005 Free PMC article. No abstract available.
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Szadai L, Bartha A, Parada IP, Lakatos AIT, Pál DMP, Lengyel AS, de Almeida NP, Jánosi ÁJ, Nogueira F, Szeitz B, Doma V, Woldmar N, Guedes J, Ujfaludi Z, Pahi ZG, Pankotai T, Kim Y, Győrffy B, Baldetorp B, Welinder C, Szasz AM, Betancourt L, Gil J, Appelqvist R, Kwon HJ, Kárpáti S, Kuras M, Murillo JR, Németh IB, Malm J, Fenyö D, Pawłowski K, Horvatovich P, Wieslander E, Kemény LV, Domont G, Marko-Varga G, Sanchez A. Szadai L, et al. Among authors: nemeth ib. Front Oncol. 2024 Jul 2;14:1428182. doi: 10.3389/fonc.2024.1428182. eCollection 2024. Front Oncol. 2024. PMID: 39015503 Free PMC article.
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.
Maul LV, Jamiolkowski D, Lapides RA, Mueller AM, Hauschild A, Garbe C, Lorigan P, Gershenwald JE, Ascierto PA, Long GV, Wang-Evers M, Scolyer RA, Saravi B, Augustin M, Navarini AA, Legge S, Németh IB, Jánosi ÁJ, Mocellin S, Feller A, Manstein D, Zink A, Maul JT, Buja A, Adhikari K, Roider E. Maul LV, et al. Among authors: nemeth ib. JAMA Netw Open. 2024 Feb 5;7(2):e2356479. doi: 10.1001/jamanetworkopen.2023.56479. JAMA Netw Open. 2024. PMID: 38363565 Free PMC article.
Mitochondrial and immune response dysregulation in melanoma recurrence.
Szadai L, Guedes JS, Woldmar N, de Almeida NP, Jánosi ÁJ, Rajeh A, Kovács F, Kriston A, Migh E, Wan G, Nguyen N, Oskolás H, Appelqvist R, Nogueira FC, Domont GB, Yu KH, Semenov ER, Malm J, Rezeli M, Wieslander E, Fenyö D, Kemény L, Horvath P, Németh IB, Marko-Varga G, Gil J. Szadai L, et al. Among authors: nemeth ib. Clin Transl Med. 2023 Nov;13(11):e1495. doi: 10.1002/ctm2.1495. Clin Transl Med. 2023. PMID: 37990633 Free PMC article. No abstract available.
Tumour regression predicts better response to interferon therapy in melanoma patients: a retrospective single centre study.
Mezőlaki NE, Baltás E, Ócsai HL, Varga A, Korom I, Varga E, Németh IB, Kis EG, Varga J, Kocsis Á, Gyulai R, Bukva M, Kemény L, Oláh J. Mezőlaki NE, et al. Among authors: nemeth ib. Melanoma Res. 2024 Feb 1;34(1):54-62. doi: 10.1097/CMR.0000000000000935. Epub 2023 Nov 13. Melanoma Res. 2024. PMID: 37962233 Free PMC article.
50 results